References
- Sulak PJ. Oral contraceptives: therapeutic uses and quality-of-life benefits — case presentations. Contraception 1999;59 Suppl 1:35S —8S.
- Sidney S, Siscovick DS, Petitti DB, Schwartz SM, Queesn-berry CP, Psaty BM, et al. Myocardial infarction and use of low-dose oral contraceptives: A pooled analysis of 2 US studies. Circulation 1988;98: 1058–63.
- Farley TM, Collins J, Schlesselman JJ. Hormonal contra-ception and risk of cardiovascular disease. An international perspective. Contraception 1998;57:211–30.
- Schwingl PJ, Ory HW, Visness CM. Estimates of the risk of cardiovascular death attributable to low-dose contraceptives in the United States. Am J Obstet Gynecol 1997;180(1 Pt 1):241–9.
- Anonymous. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case control study, WHO collaborative study of cardiovas-cular disease and steroid hormone contraception. Lancet 1997;349:1202–9.
- Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: Case-control study. The World Health Or-ganisation collaborative study of cardiovascular disease and steroid hormone contraception. Br Med J 1999;318:13–8.
- Barrett DH, Anda RF, Escobedo LG, Croft JB, Williamson DP, Marks JS. Trends in oral contraceptive use and cigarette smoking. Behavioral risk factor surveillance sys-tem, 1982 and 1988. Arch Fam Med 1993;3: 438–43.
- Jeune B, Wielandt H. Prevalence of smoking and oral con-traception in a sample of Danish young women. Scand J Soc Med 1991;19:44–6.